210 related articles for article (PubMed ID: 15190027)
1. Ultrastructure of Streptococcus pneumoniae after exposure to xylitol.
Tapiainen T; Sormunen R; Kaijalainen T; Kontiokari T; Ikäheimo I; Uhari M
J Antimicrob Chemother; 2004 Jul; 54(1):225-8. PubMed ID: 15190027
[TBL] [Abstract][Full Text] [Related]
2. Effect of xylitol and other carbon sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro.
Kurola P; Tapiainen T; Sevander J; Kaijalainen T; Leinonen M; Uhari M; Saukkoriipi A
APMIS; 2011 Feb; 119(2):135-42. PubMed ID: 21208281
[TBL] [Abstract][Full Text] [Related]
3. Xylitol and capsular gene expression in Streptococcus pneumoniae.
Kurola P; Tapiainen T; Kaijalainen T; Uhari M; Saukkoriipi A
J Med Microbiol; 2009 Nov; 58(Pt 11):1470-1473. PubMed ID: 19589898
[TBL] [Abstract][Full Text] [Related]
4. Effect of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol.
Tapiainen T; Kontiokari T; Sammalkivi L; Ikäheimo I; Koskela M; Uhari M
Antimicrob Agents Chemother; 2001 Jan; 45(1):166-9. PubMed ID: 11120960
[TBL] [Abstract][Full Text] [Related]
5. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
6. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
[TBL] [Abstract][Full Text] [Related]
7. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
[TBL] [Abstract][Full Text] [Related]
8. Effect of xylitol on growth of nasopharyngeal bacteria in vitro.
Kontiokari T; Uhari M; Koskela M
Antimicrob Agents Chemother; 1995 Aug; 39(8):1820-3. PubMed ID: 7486925
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
[TBL] [Abstract][Full Text] [Related]
10. Xylitol in preventing acute otitis media.
Uhari M; Tapiainen T; Kontiokari T
Vaccine; 2000 Dec; 19 Suppl 1():S144-7. PubMed ID: 11163479
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
Hatakka K; Blomgren K; Pohjavuori S; Kaijalainen T; Poussa T; Leinonen M; Korpela R; Pitkäranta A
Clin Nutr; 2007 Jun; 26(3):314-21. PubMed ID: 17353072
[TBL] [Abstract][Full Text] [Related]
12. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren.
Jain A; Kumar P; Awasthi S
Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507
[TBL] [Abstract][Full Text] [Related]
13. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
Garbutt J; Rosenbloom I; Wu J; Storch GA
Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
[TBL] [Abstract][Full Text] [Related]
14. Antiadhesive effects of xylitol on otopathogenic bacteria.
Kontiokari T; Uhari M; Koskela M
J Antimicrob Chemother; 1998 May; 41(5):563-5. PubMed ID: 9630410
[TBL] [Abstract][Full Text] [Related]
15. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis.
Pichichero ME
Clin Pediatr (Phila); 2006 Jul; 45(6):493-502. PubMed ID: 16893853
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
17. Seasonal distribution of otitis media pathogens among Costa Rican children.
Guevara S; Soley C; Arguedas A; Porat N; Dagan R
Pediatr Infect Dis J; 2008 Jan; 27(1):12-6. PubMed ID: 18162931
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of Streptococcus mutans under prolonged exposure to xylitol, without reculture].
Almarza-Ortega D; Gómez ME; Del Villar A; Esparza D
Invest Clin; 1994 Jun; 35(2):77-90. PubMed ID: 7918760
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nasopharyngeal culture in identification of pathogen in middle ear fluid in chronic otitis media with effusion.
Eser OK; Ipci K; Alp S; Akyol U; Unal OF; Hascelik G; Sennaroglu L; Gür D
Indian J Med Microbiol; 2009; 27(3):237-41. PubMed ID: 19584505
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
